6RT-20222-74433
4 vaccinations
2 coded responses
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 060 / CT
- Registered
- 2022-11-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-20
Dose 1 — Pfizer-BioNTech
-
2021-03-13
Dose 2 — Pfizer-BioNTech
-
2021-11-11
Dose 3 — Pfizer-BioNTech
-
2022-11-10
Registered in v-safe
-
2022-11-10
Dose 4 — Pfizer-BioNTech
- 2022-11-10
- 2022-11-11
- 2022-11-12
- 2022-11-13
- 2022-11-14
- 2022-11-15
- 2022-11-16
- 2022-11-17
- 2022-11-24
- 2022-12-01
-
2022-12-08
Survey response — day 28, dose 4MedDRA: Nasopharyngitis, Respiratory tract congestion, Throat irritation — Feeling: FairFree text: Cold like symptoms, congestion mostly, scratchy throat on & off.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-15
- 2022-12-22
-
2023-02-11
Survey response — 3 months, dose 4MedDRA: SARS-CoV-2 test positive — Feeling: FairMedDRA releases: 2024-11
- 2023-05-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-20 | Pfizer-BioNTech | No |
| 2 | 2021-03-13 | Pfizer-BioNTech | No |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
| 4 | 2022-11-10 | Pfizer-BioNTech | No |
Free text
Release 12 — day 28, dose 4
Symptoms: Cold like symptoms, congestion mostly, scratchy throat on & off.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release